| Literature DB >> 26448748 |
Matteo Monami1, Stefania Zannoni1, Marianna Gaias1, Besmir Nreu1, Niccolò Marchionni1, Edoardo Mannucci2.
Abstract
Background. Patient education is capable of reducing the risk for diabetic foot ulcers. However, specific education on foot ulcer prevention was either included in broader programs addressing different parts of diabetes care or provided with time- and resource-consuming curricula. The aim of the study is to assess the feasibility and efficacy of a brief educational program for the prevention of diabetic foot ulcers in high-risk patients. Methods. The study was performed on type 2 diabetic patients, randomized in a 1 : 1 ratio either to intervention or to control group. The principal endpoint was the incidence of foot ulcers. The intervention was a two-hour program provided to groups of 5-7 patients, including a 30-minute face-to-face lesson on risk factors for foot ulcers, and a 90-minute interactive session with practical exercises on behaviors for reducing risk. Results. The study was prematurely terminated due to a highly significant difference in outcome between the two treatment groups. The final sample was therefore composed of 121 patients. Six patients, all in the control group, developed ulcers during the 6-month follow-up (10% versus 0%, p = 0.012). Conclusions. A brief, 2-hour, focused educational program is effective in preventing diabetic foot ulcers in high-risk patients.Entities:
Year: 2015 PMID: 26448748 PMCID: PMC4581554 DOI: 10.1155/2015/615680
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Baseline demographic and clinical characteristics of the patients enrolled.
| Standard care | Educational program |
| |
|---|---|---|---|
| Number | 60 | 60 | — |
| Gender (women, %) | 28 (46.7) | 20 (33.3) | 0.14 |
| Age (years) | 69.4 ± 11.3 | 72.0 ± 8.9 | 0.11 |
| Duration of diabetes (years) | 15.9 ± 11.2 | 14.2 ± 12.4 | 0.48 |
| BMI (Kg/m2) | 30.0 ± 5.6 | 29.4 ± 4.7 | 0.61 |
| Waist circumference (cm) | 106.4 ± 13.9 | 104.2 ± 11.1 | 0.51 |
| HbA1c (%) | 7.3 ± 1.4 | 7.4 ± 1.3 | 0.86 |
| Systolic pressure (mmHg) | 139 ± 19 | 136 ± 17 | 0.41 |
| Diastolic pressure (mmHg) | 75 ± 10 | 79 ± 16 | 0.24 |
| Smokers/ex-smokers (%) | 20 (33.3) | 21 (35) | 0.59 |
| Charlson's comorbidity score | 2.9 ± 2.8 | 3.0 ± 2.7 | 0.87 |
|
| 20 [16; 22] | 19 [16; 20] | 0.65 |
| Medical history (%) | |||
| Peripheral artery disease | 10 (16.7) | 5 (8.3) | 0.17 |
| Neuropathy | 48 (80.0) | 50 (83.3) | 0.89 |
| Previous ulcers | 6 (9.9) | 7 (11.7) | 0.49 |
| Foot abnormalities | 6 (9.9) | 3 (4.9) | 0.37 |
| Retinopathy | 4 (6.7) | 10 (16.7) | 0.088 |
| Chronic renal failure‡ | 6 (10.0) | 7 (11.7) | 0.77 |
| Cardiac disease† | 18 (30.0) | 18 (30.0) | >0.99 |
| Chronic heart failure | 6 (10.0) | 5 (8.3) | 0.75 |
| Cerebrovascular disease†† | 6 (10.0) | 4 (6.7) | 0.51 |
| Nonmetastatic malignancies | 4 (6.7) | 5 (8.3) | 0.73 |
| Treatment (%) | |||
| Insulin | 12 (20.0) | 17 (28.3) | 0.29 |
| Antihypertensive | 46 (76.7) | 50 (83.3) | 0.71 |
| Statin | 28 (46.7) | 25 (41.7) | 0.67 |
| Antiaggregant/coagulant | 50 (83.3) | 52 (86.7) | 0.78 |
In absence of neuropathy; data are expressed as number (%) and mean ± SD; †previous myocardial infarction and/or angina pectoris; ††previous stroke or transient ischemic attack; ‡creatinine >1.2 mg/dL.
Selected clinical parameters at 6-month follow-up.
| Standard care | Educational program |
| |
|---|---|---|---|
| Number | 60 | 60 | — |
| BMI (Kg/m2) | 30.1 ± 5.7 | 29.5 ± 4.6 | 0.29 |
| HbA1c (%) | 7.3 ± 1.4 | 7.1 ± 1.2 | 0.37 |
| Systolic pressure (mmHg) | 136 ± 15 | 137 ± 18 | 0.62 |
| Diastolic pressure (mmHg) | 77 ± 11 | 78 ± 16 | 0.65 |
Data are expressed as number (%) and mean ± SD.
Figure 1Kaplan-Meier survival curves (patients free of event) for incidence of foot ulcers in intervention (grey line) and control (black line) groups. p = 0.012.